DNA research

Investing in new medicine

Mission

The business world is rapidly changing. Traditional industries disappear as new ones arise. The chemical industry, which was the engine of economic growth for decades in many countries has to make place for the biotechnology industry. In this new millennium biotechnology will become as important as the computer is to us today (experts say healthcare spending is outpacing the growth of the American economy and will consume 20 percent of gross domestic product by 2015).

The enormous progress in biotechnology will most certainly lead to very promising stock performance for the companies involved. We all know examples of people who got rich, because they invested in the right sector at the right time.

We are starting to see a vast array of products, deriving from modern biotechnology (new medicines in oncology, auto immune disorders, next generation antibiotics, new diagnostic devices, pest- resistant crops, bio-filters to clean up the environment, etc.). These products will create a market for many hundreds of billions of dollars.

Investors that realize the future importance of biotechnology need a vehicle that allows them to participate. Our company offers such a vehicle in a way that investors can take advantage of this promising market, while leaving key decisions to specialists.

 

J. Lamarck Srl - Via di S. Antonio, 4 - 37122 Verona - Italia - Tel. +39.045.8015428 - Fax. +39.045.8015433 - P.iva IT 02684320233
Homepage | The company | Investing in Biotechnology | Mission | Strategy | Our service | News | Contact us | Italiano